Yan Peng

10PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersMolecular targetsOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 05, 2026
Endotrophin is a circulating fibroinflammatory biomarker associated with treatment response in human metastatic ER+ breast cancer.

|Dec 30, 2025
The Molecular Landscape and Utility of Multiomic Analyses in Triple-Negative Breast Cancer: Further Subtyping and Exploring Novel Biomarkers and Therapeutic Targets.

Conan Juan, Yan Peng

|Jul 14, 2025
A Four Amino Acid Intracellular Motif of VISTA Blocks Growth Receptor Signaling in Cancer Cells to Induce Tumor Suppression.

Yan Zhao, Tina Andoh, Fatima Charles

|Feb 13, 2025
Unique Molecular Alteration of Lobular Breast Cancer: Association with Pathological Classification, Tumor Biology and Behavior, and Clinical Management.

Huina Zhang, Yan Peng

|Jan 08, 2024
AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer.

Mauricio Marquez-Palencia, Luis Reza Herrera, Pravat Kumar Parida

|Jan 08, 2023
Current Biological, Pathological and Clinical Landscape of HER2-Low Breast Cancer.

Huina Zhang, Yan Peng

Pageof 2

Frequent Collaborators

2 joint publications

Yang Zhang

2 joint publications

Joshua J Gruber

2 joint publications

Cheryl M Lewis

1 joint publications

Laura E Herring